PCSA
Processa Pharmaceuticals Inc
NASDAQ: PCSA · HEALTHCARE · BIOTECHNOLOGY
$2.70
+1.89% today
Updated 2026-04-30
Market cap
$7.93M
P/E ratio
—
P/S ratio
1,320.06x
EPS (TTM)
$-10.36
Dividend yield
—
52W range
$2 – $20
Volume
0.1M
Processa Pharmaceuticals Inc (PCSA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $140000.00 | $20000.00 | $192145.00 | $312480.00 | $200201.00 | $113425.00 | $113425.00 | $5000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -85.7% | +860.7% | +62.6% | -35.9% | -43.3% | +0.0% | -95.6% | -100.0% | — | — | — | — | — | — | — |
| Cost of revenue | $150000.00 | $525.00 | $133255.00 | $188000.00 | $113251.00 | $125876.00 | $125876.00 | $1381.00 | $630092.00 | $877897.00 | $882062.00 | $875349.00 | $874013.00 | $222.00 | $782.00 | $1204.00 |
| Gross profit | $-10000.00 | $20000.00 | $58890.00 | $124478.00 | $86950.00 | $-12451.00 | $-12451.00 | $-1865.00 | $-630092.00 | $-877897.00 | $-882062.00 | $-875349.00 | $-874013.00 | $-222.00 | $-782.00 | $-1204.00 |
| Gross margin | -7.1% | 100.0% | 30.6% | 39.8% | 43.4% | -11.0% | -11.0% | -37.3% | — | — | — | — | — | — | — | — |
| R&D | $110000.00 | $170000.00 | $448028.00 | $267062.00 | $189745.00 | $29246.00 | $29246.00 | $926117.00 | $3.09M | $2.32M | $11.08M | $6.88M | $11.49M | $5.80M | $7.27M | $7.81M |
| SG&A | $40000.00 | $610000.00 | $1.88M | $2.82M | $2.84M | $945460.00 | $945460.00 | $876316.00 | $1.44M | $1.61M | $3.26M | $4.69M | $8.76M | $5.66M | $4.78M | $6.18M |
| Operating income | $-160000.00 | $-770000.00 | $-2.27M | $-2.96M | $-4.16M | $-987157.00 | $2.69M | $-1.80M | $-4.52M | $-3.94M | $-15.14M | $-12.13M | $-27.53M | $-11.46M | $-12.05M | $-13.99M |
| Operating margin | -114.3% | -3850.0% | -1182.8% | -947.7% | -2078.1% | -870.3% | 2372.6% | -36048.7% | — | — | — | — | — | — | — | — |
| EBITDA | $-160000.00 | $-1.11M | $-2.16M | $-2.54M | $-2.94M | $-748335.00 | $-2.51M | $-1.80M | $-3.88M | $-3.05M | $-14.25M | $-10.78M | $-19.47M | $-11.46M | $-12.05M | $-13.99M |
| EBITDA margin | -114.3% | -5550.0% | -1124.8% | -814.1% | -1469.5% | -659.8% | -2211.5% | -35907.7% | — | — | — | — | — | — | — | — |
| EBIT | $-160000.00 | $-770000.00 | $-2.27M | $-2.96M | $-3.40M | $-987157.00 | $-2.75M | $-1.80M | $-4.51M | $-3.92M | $-15.13M | $-11.57M | $-20.26M | $-11.46M | $-12.05M | $-13.99M |
| Interest expense | $0.00 | $170000.00 | $170715.00 | $109725.00 | $315304.00 | $0.00 | $235644.00 | $35693.00 | $161205.00 | $36658.00 | $281122.00 | $362.00 | $101202.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-160000.00 | $-940000.00 | $-2.44M | $-3.07M | $-4.53M | $-3.35M | $-3.35M | $-1.86M | $-3.77M | $-3.36M | $-19.04M | $-11.43M | $-27.42M | $-11.12M | $-11.85M | $-13.56M |
| Net income growth (YoY) | — | -487.5% | -159.6% | -25.7% | -47.5% | +25.9% | +0.0% | +44.7% | -102.8% | +10.8% | -467.0% | +40.0% | -140.0% | +59.4% | -6.6% | -14.5% |
| Profit margin | -114.3% | -4700.0% | -1270.2% | -982.0% | -2260.9% | -2957.2% | -2957.2% | -37126.3% | — | — | — | — | — | — | — | — |